Together these data suggest that either a loss of Claspin could be responsible for an earlier onset of tumourigenesis in the DEN model and/or, the loss could increase the probability that cells undergo malignant transformation, increasing adenoma–carcinoma progression. The gene discussed is CLSPN; the disease is adenoma.